Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,065 | 20,435 | 3,003 | N/A | N/A |
| Receivables | 86 | 86 | N/A | N/A | N/A |
| TOTAL | $19,336 | $20,588 | $3,007 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 22 | 20 | 20 | N/A | N/A |
| Other Non-Current Assets | 20 | 12 | 486 | 0 | 0 |
| TOTAL | $43 | $32 | $505 | $N/A | $N/A |
| Total Assets | $19,379 | $20,620 | $3,512 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 313 | 448 | 418 | 0 | 0 |
| Accrued Expenses | 212 | 325 | 269 | N/A | N/A |
| TOTAL | $524 | $773 | $687 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $524 | $773 | $687 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,528 | 12,528 | 12,517 | N/A | N/A |
| Common Shares | 13 | 13 | 7 | N/A | N/A |
| Retained earnings | -7,011 | -5,759 | -5,018 | N/A | N/A |
| TOTAL | $18,854 | $19,847 | $2,826 | $N/A | $N/A |
| Total Liabilities And Equity | $19,379 | $20,619 | $3,512 | $0 | $0 |